|
MedChemExpress
abt 737 Abt 737, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/ABT-737/pmc13626084-309-0-8 Average 96 stars, based on 1 article reviews
abt 737 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
TargetMol
cas 115144 35 9 abt 737 Cas 115144 35 9 Abt 737, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/ABT-737/pm42392927-277-93-97 Average 94 stars, based on 1 article reviews
cas 115144 35 9 abt 737 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
abt 263 ![]() Abt 263, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/Navitoclax/pmc13679333-137-0-3 Average 97 stars, based on 1 article reviews
abt 263 - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
MedChemExpress
1 abt ![]() 1 Abt, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/1-Aminobenzotriazole/pmc13489435-228-9-10 Average 94 stars, based on 1 article reviews
1 abt - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
abt 199 ![]() Abt 199, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/Venetoclax/10__1038_slash_s41420___026___03298___2-59-11-9 Average 97 stars, based on 1 article reviews
abt 199 - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
MedChemExpress
abt ![]() Abt, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/Navitoclax/bio_rxiv__64898__2026__08__03__740778-70-9-17 Average 97 stars, based on 1 article reviews
abt - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
MedChemExpress
veliparib abt 888 medchem express ![]() Veliparib Abt 888 Medchem Express, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abts/Olaparib/pm41935526-166-269-271 Average 97 stars, based on 1 article reviews
veliparib abt 888 medchem express - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
Journal: Cancer research
Article Title: Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer
doi: 10.1158/0008-5472.CAN-26-0493
Figure Lengend Snippet: A, Western blot analysis of Myc-CaP cells following 6-day treatment with DMSO, docetaxel (3.75μM), palbociclib (1μM), or PF-06873600 (500nM). B-C, Heatmaps displaying BCL2 ( B ) and IAP ( C ) family gene expression in Myc-CaP cells treated with DMSO, Nutlin-3 (10μM), palbociclib (1μM), T/P (25nM/1μM), PF-06873600 (500nM), alisertib (500nM), etoposide (500nM), or docetaxel (3.75μM) for 6 days from RNA-seq analysis (n=3/group). D, Representative clonogenic images of Myc-CaP cells pre-treated with DMSO or indicated drugs as in B , followed by replatement and treatment with ABT-263 (1μM) or DMSO for 48 hrs. Quantification of Crystal Violet staining is shown (n=3/group). E, Representative clonogenic images of Myc-CaP cells pre-treated with docetaxel for 6 days, followed by replatement and treatment with LCL161 (1μM), TNFα (160ng/ml), and/or Z-VAD (20μM) for 48 hrs. Quantification of Crystal Violet staining is shown (n=3/group). F, Western blot analysis of Myc-CaP cells pre-treated with docetaxel for 6 days, followed by replatement and treatment with DMSO, ABT-263, or LCL161/TNFα for 6 hrs. G, Quantification of clonogenic growth in Myc-CaP cells pre-treated with 3.75μM docetaxel for 6 days, followed by replatement and treatment with ABT-263 (1μM), LCL161 (1μM), TNFα (160ng/ml), MCC950 (1μM), and/or Nec-1 (10μM) for 48 hrs (n=3/group). H, Cytokine array analysis in Myc-CaP cells treated as in F . Data represent mean ± SEM. Statistical significance was determined by one-way ANOVA. NS, not significant.
Article Snippet:
Techniques: Western Blot, Analysis, Gene Expression, RNA Sequencing, Staining
Journal: Cancer research
Article Title: Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer
doi: 10.1158/0008-5472.CAN-26-0493
Figure Lengend Snippet: A, Schematic of Myc-CaP orthotopic transplantation into FVB mice and treatment schedule. Created in BioRender. Zhou, L. (2026) https://BioRender.com/bz5q63y . B , Representative IHC staining of Myc-CaP prostate tumors from mice treated with vehicle, docetaxel (10mg/kg), ABT-263 (50mg/kg), and/or LCL161 (75mg/kg) for 2 weeks. Scale bar, 100μm. Quantification of number of p21 + /p16 + senescent cells and CC3 + /CC8 + dead cells/field is shown inset (n=3 mice/group). Images and values for vehicle/docetaxel conditions are the same shown in Fig. 4B . C , Cytokine array analysis of Myc-CaP tumors from mice treated as in B (n=2 mice/group). Statistical significance could not be determined due to low sample number. Values for vehicle/docetaxel conditions are the same shown in Fig. 4C ; Supplementary Fig.6A . D-F , Flow cytometry analysis of CD8 + T cell numbers and activation markers ( D ), iMCs ( E ), and DC populations ( F ) in Myc-CaP tumors from mice treated as in B (n=7-8 mice/group). Values for vehicle/docetaxel conditions are the same shown in Fig. 4E ; Supplementary Fig.6C . G , Waterfall plot of the response of Myc-CaP tumors to treatment as in B (n=5-8 mice/group). Values for vehicle/docetaxel conditions are the same shown in Fig. 4G . Each bar represents an individual mouse. H, Quantification of ascites volume in Myc-CaP tumor-bearing mice treated as in B (n=7-8 mice/group). Values for vehicle/docetaxel conditions are the same shown in Fig.4H . I, Representative H&E staining of liver metastases (outlined in black) in Myc-CaP tumor-bearing mice treated as in B. Scale bar, 50μm. Quantification of percentage of mice with liver metastasis is shown (n=3-5 mice/group). Images and values for vehicle/docetaxel conditions are the same shown in Fig. 4I . Data represent mean ± SEM. Statistical significance was determined by one-way ANOVA. NS, not significant.
Article Snippet:
Techniques: Transplantation Assay, Immunohistochemistry, Analysis, Flow Cytometry, Activation Assay, Staining
Journal: PLOS Biology
Article Title: Heme acts as a metabolic brake on erebosis in the Drosophila gut
doi: 10.1371/journal.pbio.3003942
Figure Lengend Snippet: (A) Feeding of CYP P450 inhibitors 1-Aminobenzotriazole (1-ABT) or piperonylbutoxide (PBO) does not restore the inhibition of erebosis by heme. 1-ABT with Ho RNAi and PBO with Mrp5 RNAi result in >50% class0 and no class2, which is similar to Ho RNAi or Mrp5 RNAi with DMSO. (B) ROS levels are not increased by Mrp5 RNAi . Using hsFLP system, Mrp5 RNAi was induced only in GFP+ cells. ROS probe dihydroethidium (DHE, magenta) is not changed in GFP+ Mrp5 RNAi cells (dashed line). (C) Ho RNAi or Mrp5 RNAi does not increase signals of lipid peroxide probe Liperfluo (green), while bleomycin increases them. (D) Feeding of a reducing agent N-acetylcysteine (NAC) does not increase erebosis. P values were calculated using Fisher’s exact test (A, D) and adjusted with the Benjamini–Hochberg method (D). Scale bars, 50 μm.
Article Snippet: Flies were fed with standard food with 15 μM
Techniques: Inhibition